Precision Medicine: Genetic Repair of Retinitis Pigmentosa in Patient-Derived Stem Cells – Nature.com
Iowa Now |
Precision Medicine: Genetic Repair of Retinitis Pigmentosa in Patient-Derived Stem Cells
Nature.com Induced pluripotent stem cells (iPSCs) generated from patient fibroblasts could potentially be used as a source of autologous cells for transplantation in retinal disease. Patient-derived iPSCs, however, would still harbor disease-causing mutations. Scientists Fix Retinitis Pigmentosa in Patient-Derived Stem Cells With CRISPR/Cas9 Edited stem cells offer hope of precision therapy for blindness |
